SLC6A3 and depressive symptom measurement: Furthermore, the simultaneous increase in the concentration of the dopamine transporter (DAT) decreased the levels of 5-HT and DA in the synaptic cleft and led to disorders in neurotransmitter metabolism, eventually inducing depression [31].